Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lonza Group's share price for the quarter that ended in Dec. 2023 was $42.09. Lonza Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 721 Mil. Therefore, Lonza Group's market cap for the quarter that ended in Dec. 2023 was $30,354 Mil.
Lonza Group's quarterly market cap
increased
from Dec. 2022 ($36,212 Mil) to Jun. 2023 ($44,331 Mil) but then
declined
from Jun. 2023 ($44,331 Mil) to Dec. 2023 ($30,354 Mil).
Lonza Group's annual market cap
declined
from Dec. 2021 ($61,948 Mil) to Dec. 2022 ($36,212 Mil) and
declined
from Dec. 2022 ($36,212 Mil) to Dec. 2023 ($30,354 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lonza Group's Enterprise Value for Today is $43,362 Mil.
Lonza Group Market Cap Historical Data
The historical data trend for Lonza Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lonza Group's Market Cap
For the Diagnostics & Research subindustry, Lonza Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lonza Group's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's Market Cap distribution charts can be found below:
* The bar in red indicates where Lonza Group's Market Cap falls into.
Lonza Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Lonza Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lonza Group (OTCPK:LZAGY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Lonza Group Market Cap Related Terms
Thank you for viewing the detailed overview of Lonza Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LZAGY has been successfully added to your 